The Patent Finder

Synaptogenix, Inc.

4 patents currently held · Updated Nov 19, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
1
Ending by 2030
Jul 2029
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 2 fees due May 21 to 28, 2027 · next May 21

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 4 of 4

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 11,820,745Pkc-Activating Compounds for the Treatment of Neurodegenerative Diseases
In force
 · High confidence
In forceHigh confidence
US 12,016,837Halogenated esters of cyclopropanated unsaturated fatty acids for use in the treatment of neurodegenerative diseases
In force
 · USPTO record
In forceUSPTO record
US 11,826,345Dosing regimens of PKC activators
In force
 · USPTO record
In forceUSPTO record
US 11,045,447Methods for Inducing Synaptogenesis with Synaptic Growth Factor Activating Compounds
In force
 · Medium confidence
In forceMedium confidence
Also on record, not counted in the 4: 2 lapsed for an unpaid fee. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

4 pending · 3 abandoned · 3 no status recorded

Showing 1 to 10 of 10, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.

ApplicationTitleFiledStatus
18/944,619Treatment of Amyotrophic Lateral Sclerosis Using PKC ActivatorsNov 12, 2024Pending
18/797,869Methods of Treating and Preventing Neurodegenerative Diseases with HGF Activating CompoundsAug 8, 2024Pending
18/740,967Jun 12, 2024No status recorded
18/375,745Pkc-Activating Compounds for the Treatment of Neurodegenerative DiseasesOct 2, 2023Abandoned
18/547,266Treatment of Multiple Sclerosis Using PKC ActivatorsFeb 8, 2022Pending
18/547,252Treatment of Optic Nerve Inflammation Using PKC ActivatorsFeb 8, 2022Pending
17/551,493Dec 15, 2021No status recorded
17/362,131Jun 29, 2021No status recorded
17/351,410Methods and Compositions for Treatment of Alzheimer's Disease and Other Neurodegenerative DisordersJun 18, 2021Abandoned
17/138,214Methods of Treating and Preventing Neurodegenerative Diseases with HGF Activating CompoundsDec 30, 2020Abandoned
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited